ScienceDaily (Apr. 30, 2012) ? UC Davis researchers have found novel compounds that disrupt the formation of amyloid, the clumps of protein in the brains of people with Alzheimer's disease believed to be important in causing the disease's characteristic mental decline. The so-called "spin-labeled fluorene compounds" are an important new target for researchers and physicians focused on diagnosing, treating and studying the disease.
The study was published April 30 in the online journal PLoS ONE.
"We have found these small molecules to have significant beneficial effects on cultured neurons, from protecting against toxic compounds that form in neurons to reducing inflammatory factors," said John C. Voss, professor of biochemistry and molecular medicine at the UC Davis School of Medicine and the principal investigator of the study. "As a result, they have great potential as a therapeutic agent to prevent or delay injury in individuals in the earliest stages of Alzheimer's disease, before significant damage to the brain occurs."
Amyloid is an accumulation of proteins and peptides that are otherwise found naturally in the body. One component of amyloid ? the amyloid beta (A?) peptide ? is believed to be primarily responsible for destroying neurons in the brain. Fluorene compounds, which are small three-ringed molecules, originally were developed as imaging agents to detect amyloid with PET imaging. In addition to being excellent for detecting amyloid, fluorenes bind and destabilize A? peptide and thereby reduce amyloid formation, according to previous findings in mice by Lee-Way Jin, another study author and associate professor in the UC Davis MIND Institute and Department of Medical Pathology and Laboratory Medicine.
The current research studied the effects of fluorene compounds by attaching a special molecule to make their activity evident using electron paramagnetic resonance (EPR) spectroscopy. This technology allows researchers to observe very specific activities of molecules of interest because biological tissues do not emit signals detectable by EPR. Since Voss was interested in the activity of fluorenes, he added a nitroxide "spin label," a chemical species with a unique signal that can be measured by EPR.
The group found that spin-labeled compounds disrupted A? peptide formation even more effectively than did non-labeled fluorenes. In addition, the antioxidant properties of the nitroxide, which scavenge reactive oxygen species known to damage neurons and increase inflammation, significantly contributed to the protective effects on neurons.
"The spin-labeled fluorenes demonstrated a number of extremely important qualities: They are excellent for detecting amyloid in imaging studies, they disrupt A? formation, and they reduce inflammation," said Voss. "This makes them potentially useful in the areas of research, diagnostics and treatment of Alzheimer's disease."
Alzheimer's disease is the most common form of dementia and affects some 5 million Americans. Current medications used to fight the disease usually have only small and temporary benefits, and commonly have many side effects.
A major obstacle in developing Alzheimer's disease therapy is that most molecules will not cross the blood-brain barrier, so that potential treatments given orally or injected into the bloodstream cannot enter the brain where they are needed. Fluorene compounds are small molecules that have been shown to penetrate the brain well.
"We have brought together expertise from diverse fields to get to this point, and what was once a side interest has become a major focus," said Voss. "We are very excited and hopeful that these unique compounds can become extremely important."
Voss' group next plans to study the safety of spin-labeled fluorene compounds as well as their efficacy for treating models of Alzheimer's disease in small animals.
Other UC Davis study authors include Jitka Petrlova and Robin Altman, also of the Department of Biochemistry and Molecular Medicine; Izumi Maezawa and Seok Hong of the MIND Institute and the Department of Pathology and Laboratory Medicine; and Daniel A. Bricarello and Atul N. Parikh of the Department of Applied Science. Other authors are Tam?s K?lai and K?lm?n Hideg of the University of Pecs, Institute of Organic and Medicinal Chemistry in Hungary, and Ghimire Harishchandra and Gary A. Lorigan of the Department of Chemistry and Biochemistry at Miami University in Oxford, Ohio.
This work was funded by grants from the U.S. National Institutes of Health (R01 AG029246) and the Hungarian National Research Fund OTKA T81123.
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by University of California - Davis Health System.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- Jitka Petrlova, Tam?s K?lai, Izumi Maezawa, Robin Altman, Ghimire Harishchandra, Hyun-Seok Hong, Daniel A. Bricarello, Atul N. Parikh, Gary A. Lorigan, Lee-Way Jin, K?lm?n Hideg, John C. Voss. The Influence of Spin-Labeled Fluorene Compounds on the Assembly and Toxicity of the A? Peptide. PLoS ONE, 2012; 7 (4): e35443 DOI: 10.1371/journal.pone.0035443
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
march of dimes james randi wargames blake griffin dunk florida primary full force odd fellows
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন